Cargando…
The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018
OBJECT: The hepatitis C virus (HCV) is prevalent across China, with a distinctive genotypic distribution that varies by geographical region and mode of transmission. Yunnan is one such geographical region wherein the local population continues to experience a high level of HCV infection, severely st...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366605/ https://www.ncbi.nlm.nih.gov/pubmed/37496804 http://dx.doi.org/10.3389/fcimb.2023.1092936 |
_version_ | 1785077203798589440 |
---|---|
author | Jia, Yuanyuan Zou, Xiu Yue, Wei Liu, Jin Yue, Ming Liu, Yang Liu, Li Huang, Peng Feng, Yue Xia, Xueshan |
author_facet | Jia, Yuanyuan Zou, Xiu Yue, Wei Liu, Jin Yue, Ming Liu, Yang Liu, Li Huang, Peng Feng, Yue Xia, Xueshan |
author_sort | Jia, Yuanyuan |
collection | PubMed |
description | OBJECT: The hepatitis C virus (HCV) is prevalent across China, with a distinctive genotypic distribution that varies by geographical region and mode of transmission. Yunnan is one such geographical region wherein the local population continues to experience a high level of HCV infection, severely straining public health resources. This high prevalence is likely due to the increased incidence of intravenous drug use in that region, as Yunnan is a major point of entry for illegal heroin into China. METHODS: We investigated 510 individuals with chronic HCV infections in Yunnan Province from 2008 through 2018. Using reverse transcription PCR and Sanger sequencing to amplify and sequence samples. Bayesian analyses was performed to estimate the common ancestors and Bayesian skyline plot to estimate the effective viral population size. Molecular network was conducted to explore the characteristics of HCV transmission. RESULTS: We successfully amplified and sequenced a total of 503 viral samples and genotyped each as either 3b (37.6%), 3a (21.9%), 1b (19.3%), 2a (10.5%), HCV-6 (10.1%), or 1a (0.6%). Over this 11-year period, we observed that the proportion of 3a and 3b subtypes markedly increased and, concomitantly, that the proportion of 1b and 2a subtypes decreased. We also performed Bayesian analyses to estimate the common ancestors of the four major subtypes, 1b, 2a, 3a, and 3b. Finally, we determined that our Bayesian skyline plot and transmission network data correlated well with the changes we observed in the proportions of HCV subtypes over time. CONCLUSIONS: Taken together, our results indicate that the prevalence of HCV 3a and 3b subtypes is rapidly increasing in Yunnan, thus demonstrating a steadily growing public health requirement to implement more stringent preventative and therapeutic measures to curb the spread of the virus. |
format | Online Article Text |
id | pubmed-10366605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103666052023-07-26 The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 Jia, Yuanyuan Zou, Xiu Yue, Wei Liu, Jin Yue, Ming Liu, Yang Liu, Li Huang, Peng Feng, Yue Xia, Xueshan Front Cell Infect Microbiol Cellular and Infection Microbiology OBJECT: The hepatitis C virus (HCV) is prevalent across China, with a distinctive genotypic distribution that varies by geographical region and mode of transmission. Yunnan is one such geographical region wherein the local population continues to experience a high level of HCV infection, severely straining public health resources. This high prevalence is likely due to the increased incidence of intravenous drug use in that region, as Yunnan is a major point of entry for illegal heroin into China. METHODS: We investigated 510 individuals with chronic HCV infections in Yunnan Province from 2008 through 2018. Using reverse transcription PCR and Sanger sequencing to amplify and sequence samples. Bayesian analyses was performed to estimate the common ancestors and Bayesian skyline plot to estimate the effective viral population size. Molecular network was conducted to explore the characteristics of HCV transmission. RESULTS: We successfully amplified and sequenced a total of 503 viral samples and genotyped each as either 3b (37.6%), 3a (21.9%), 1b (19.3%), 2a (10.5%), HCV-6 (10.1%), or 1a (0.6%). Over this 11-year period, we observed that the proportion of 3a and 3b subtypes markedly increased and, concomitantly, that the proportion of 1b and 2a subtypes decreased. We also performed Bayesian analyses to estimate the common ancestors of the four major subtypes, 1b, 2a, 3a, and 3b. Finally, we determined that our Bayesian skyline plot and transmission network data correlated well with the changes we observed in the proportions of HCV subtypes over time. CONCLUSIONS: Taken together, our results indicate that the prevalence of HCV 3a and 3b subtypes is rapidly increasing in Yunnan, thus demonstrating a steadily growing public health requirement to implement more stringent preventative and therapeutic measures to curb the spread of the virus. Frontiers Media S.A. 2023-07-11 /pmc/articles/PMC10366605/ /pubmed/37496804 http://dx.doi.org/10.3389/fcimb.2023.1092936 Text en Copyright © 2023 Jia, Zou, Yue, Liu, Yue, Liu, Liu, Huang, Feng and Xia https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Jia, Yuanyuan Zou, Xiu Yue, Wei Liu, Jin Yue, Ming Liu, Yang Liu, Li Huang, Peng Feng, Yue Xia, Xueshan The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 |
title | The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 |
title_full | The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 |
title_fullStr | The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 |
title_full_unstemmed | The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 |
title_short | The distribution of hepatitis C viral genotypes shifted among chronic hepatitis C patients in Yunnan, China, between 2008–2018 |
title_sort | distribution of hepatitis c viral genotypes shifted among chronic hepatitis c patients in yunnan, china, between 2008–2018 |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366605/ https://www.ncbi.nlm.nih.gov/pubmed/37496804 http://dx.doi.org/10.3389/fcimb.2023.1092936 |
work_keys_str_mv | AT jiayuanyuan thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT zouxiu thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT yuewei thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT liujin thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT yueming thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT liuyang thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT liuli thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT huangpeng thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT fengyue thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT xiaxueshan thedistributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT jiayuanyuan distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT zouxiu distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT yuewei distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT liujin distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT yueming distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT liuyang distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT liuli distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT huangpeng distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT fengyue distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 AT xiaxueshan distributionofhepatitiscviralgenotypesshiftedamongchronichepatitiscpatientsinyunnanchinabetween20082018 |